Matthias Goebeler

36PUBLICATIONS
187CO-AUTHORS
AllergyMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 11, 2026
Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and Physicians.

|Mar 03, 2026
Identifying and Evaluating Patient-Centered Mobile and Web Apps for Patients With Chronic Spontaneous Urticaria: Systematic Search and Content Analysis.

Caroline Glatzel, Bernadette Glatzel, Tassilo Dege

|Jan 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Simon Goller, Tassilo Dege, Patrick Schummer

|Oct 06, 2025
MEK5/ERK5 inhibition sensitizes NRAS-mutant melanoma to MAPK-targeted therapy by preventing Cyclin D/CDK4-mediated G1/S progression.

Rupesh Paudel, Simon Goller, Felix Deutzmann

|Sep 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.

Patrick Schummer, Caroline Glatzel, Philipp Schrüfer

Pageof 6

Frequent Collaborators

7 joint publications

Tassilo Dege

6 joint publications

Bastian Schilling

6 joint publications

Marion Wobser

6 joint publications

Astrid Schmieder